Scale Biosciences (Scale Bio), a frontrunner in modern and scalable single cell evaluation options, immediately introduced the launch of the “100 Million Cell Problem,” a worldwide initiative aimed toward pushing the boundaries of single-cell genomics analysis.
This primary-of-its-kind program calls on researchers worldwide to submit proposals for large-scale single cell tasks, with the objective of collectively analyzing 100 million cells or extra throughout various organic programs and analysis areas. Chosen tasks will profit from early entry of Scale Bio’s latest workflow, QuantumScale, a single cell RNA sequencing know-how able to processing as much as 2 million cells per run with unparalleled effectivity, knowledge high quality, and low value per cell.
“The 100 Million Cell Problem represents a pivotal second in single cell genomics analysis,” stated Giovanna Prout, President and CEO of Scale Bio. “By bringing collectively researchers from varied disciplines and offering them with superior know-how from Scale Bio and our collaborators, we intention to catalyze new discoveries that may form the way forward for precision drugs, additional our understanding of complicated organic programs, and gas the explosion of generative AI that’s being leveraged in biology.”
“By bringing collectively researchers from varied disciplines and offering them with superior know-how from Scale Bio and our collaborators, we intention to catalyze new discoveries that may form the way forward for precision drugs, additional our understanding of complicated organic programs, and gas the explosion of generative AI that’s being leveraged in biology.”
Key options of the Problem embody:
- Minimal venture dimension of 1 million cells, with no most restrict
- Collaboration with industry-leading companions for sequencing and knowledge evaluation companies
- Considerably sponsored prices for library preparation and sequencing companies
Scale Bio is proud to collaborate with Ultima Genomics for correct, low-cost, and high-throughput sequencing, and NVIDIA for its accelerated computing platform. These collaborations will assist be certain that taking part researchers have entry to state-of-the-art sources all through all the workflow.
We’re excited to assist the ‘100 Million Cell Problem’ with our sequencing know-how. The magnitude of this initiative aligns completely with our mission to allow researchers to generate and entry genomic data at scale.”
Gilad Almogy, CEO, Ultima Genomics
“Successfully coaching basis fashions requires an immense quantity of information. The dramatic improve in high-resolution single cell experiments from this venture will assist considerably affect translational analysis,” stated George Vacek, World Head of Genomics Alliances at NVIDIA. “With NVIDIA GPU-powered evaluation, researchers can quickly achieve significant insights from knowledge, accelerating scientific discovery.”
Dr. Ronan Chaligne, Director, Single Cell Innovation Lab at MSK Most cancers Middle, emphasised the significance of elevated scale in single cell research: “The power to research thousands and thousands of cells in a single experiment is a game-changer. It would permit us to detect uncommon cell populations, perceive mobile heterogeneity at an unprecedented degree, and doubtlessly uncover fully new organic phenomena. This Problem will speed up our understanding of complicated illnesses and result in novel therapeutic approaches.”
Researchers involved in taking part can submit their venture proposals from August 8 to October 15, 2024. Tasks shall be evaluated on a rolling foundation as quickly as they’re submitted. Chosen tasks shall be introduced on the American Society of Human Genetics (ASHG) Annual Assembly in November 2024.
